Endocrine Flashcards
(114 cards)
Causes of hypoglycaemia?
Too much insulin, too much exercise, too little carbohydrates or combination. Alcohol Sulphonylureas Adrenal failure Liver failure Hypopituitarism Infection
Patients with DM secondary to total pancreatectomy more susceptible
What is C-peptide?
Low C-peptide = exogenous insulin
High C-peptide = endogenous insulin
Treatment of hypo if able to swallow?
Glucotabs/Glucogel, lucozade
Rpt CBG in 10-15 mins - repeat up to x3 if low
If no improvement –> IV glucose/IM glucagon
Management of hypo if unconscious?
75-100ml 20% glucose OR
150-200 ml 10% glucose over 15 mins
or IM glucagon 1mg
What to give after a hypo?
Continuous infusion of 10% glucose for 8hrs if due to insulin/sulphonylurea
Once CBG >4, long acting carbs/normal meal
CONTINUE NORMAL INSULIN DOSES
How long no driving after hypo?
45 mins
Diagnostic criteria for DKA?
Hyperglycaemia (>11mmol/L)
Acidosis (venous pH <7.3 or bicarb <15mmol/L)
Blood ketones >3mmol/L or ketonuria (>++)
When to give K+ in DKA?
Add potassium supplementation (40mmol/L after 1st bag) – max 2L.
Still give if K+ normal - only withhold K+ if >5.5 – if <3.5, GET HELP – need a central line.
Rate of infusion in DKA?
Fixed rate insulin IV infusion - 0.1 unit/kg/hr IV over a sliding scale.
50 units human soluble insulin e.g. Actrapid in 50ml 0.9% saline)
When to monitor ketones, K+ and pH in DKA?
Monitor glucose and ketones hourly, and venous HCO3-, K+ and pH at 60 min and 2 hourly thereafter; K+ will fall unless replaced.
When to stop insulin infusion in DKA?
Continue insulin infusion until ketones<0.3mmol/L and pH >7.3.
At this point convert to regular SC insulin if eating and drinking normally, otherwise using a sliding scale
Continue long acting insulin in DKA?
YES
Prevents rebound hyperglycaemia when IV stopped. Short-acting insulin stopped until about to discontinue IV
Diagnosis of T1DM?
Symptoms plus…
Random venous blood glucose >11.1 OR Fasting venous blood glucose >7.0 OR OGTT
If asymptomatic, need 2 separate results
Symptoms of diabetes?
Thirst, toilet, thinner, tired
Infections - skin, UTI, candida genital infections
HbA1c to diganose TIIDM?
48 mmol/mol
HbA1c targets in TIIDM?
Lifestyle/monotherapy - 48 mmol/mol
Hypo-associated drug - 53 mmol/mol
Dual therapy/triple therapy/insuline - 53 mmo/mol
Name, mechanism, benefits/disadvantages of biguanides?
Metformin
Decreases glucose production by liver and increases insulin sensitivity of body tissues.
Doesn’t put on weight or cause hypos, but causes bowel problems.
Not indicated if eGFR <35.
Name, mechanism, benefits/disadvantages of Sulfonylureas?
Gliclazide, glimepiride
Depolarises pancreatic beta cells, which opens voltage gated Ca2+ channels, leading to increased secretion of insulin.
Causes weight gain. Better than metformin at reducing blood glucose quickly – good if patient experiencing symptoms.
Name, mechanism, benefits/disadvantages of DDP-4 inhibitors?
Sitagliptin, alogliptin, linaliptin
Inhibits enzyme which breaks down incretin, which is released in response to oral glucose - ↓incretin –> ↓glucagon –> ↑insulin.
Linagliptin safe in renal impairment.
Name, mechanism, benefits/disadvantages of Thiazolidinediones?
Pioglitazone
Reduces insulin resistance in the liver and peripheral tissues, decreases gluconeogenesis in the liver –> reduces blood glucose.
Contraindicated in heart failure, hepatic impairment, DKA, history of bladder cancer, uninvestigated macroscopic haematuria.
Name, mechanism, benefits/disadvantages of SGLT2 Inhibitor?
Dapagliflozin, canagliflozin, empagliflozin
Inhibits reabsorption of glucose in the kidney –> lower blood sugar because peeing out glucose.
Can cause weight loss because of lost calories, but can cause UTI/thrush.
Name, mechanism of GLP-1 agonist?
Liraglutide, exendatide
Works on same pathway as DPP-4 inhibitors but are more potent.
Screening in TIIDM?
Retinopathy – screening programme
Foot problems – annual foot check
Nephropathy – annual screening (Urine ACR and eGFR)
Cardiovascular Risk Factors
Age, albuminuria, smoking status, blood glucose control, blood pressure, full lipid profile
What causes Grave’s disease?
IgG against TSH receptor
Process also directed towards soft tissues in the orbit –> inflammation and swelling